Youcare Pharmaceutical Group Co.Ltd(688658) board of supervisors
List of incentive objects first granted by the company’s restricted stock incentive plan in 2021
Verification opinions (as of the grant date)
The board of supervisors of Youcare Pharmaceutical Group Co.Ltd(688658) (hereinafter referred to as the “company”) shall, in accordance with the company law of the people’s Republic of China (hereinafter referred to as the “company law”), the securities law of the people’s Republic of China (hereinafter referred to as the “Securities Law”) and the administrative measures for equity incentive of listed companies (hereinafter referred to as the “administrative measures”) Relevant laws, regulations and normative documents such as the Listing Rules of Shanghai Stock Exchange on the Kechuang board (hereinafter referred to as the “Listing Rules”), the business guide for information disclosure of companies listed on the Kechuang board No. 4 – disclosure of equity incentive information, and the relevant provisions of the Youcare Pharmaceutical Group Co.Ltd(688658) articles of Association (hereinafter referred to as the “articles of association”), After reviewing the list of incentive objects first granted by the company’s restricted stock incentive plan in 2021 (hereinafter referred to as the “incentive plan”) (as of the grant date), the verification opinions are as follows:
1. The incentive objects granted for the first time in this incentive plan are not allowed to become incentive objects as stipulated in Article 8 of the administrative measures:
(1) Being identified as inappropriate by the stock exchange within the last 12 months;
(2) It has been identified as an inappropriate candidate by the CSRC and its dispatched offices within the last 12 months;
(3) Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations within the last 12 months;
(4) Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
(5) Those who are not allowed to participate in equity incentive of listed companies according to laws and regulations;
(6) Other circumstances recognized by the CSRC.
2. The persons included in the list of incentive objects granted for the first time in this incentive plan do not include the independent directors and supervisors of the company. Except Mr. Yu Fei and Mr. Yu Pengfei, the incentive objects do not include other shareholders who individually or jointly hold more than 5% of the shares of the listed company, the actual controllers of the listed company and their spouses, parents, children and foreign employees.
3. The list of incentive objects granted for the first time in the incentive plan is consistent with the list of incentive objects granted for the first time in the Youcare Pharmaceutical Group Co.Ltd(688658) 2021 restricted stock incentive plan (Draft) (hereinafter referred to as “incentive plan (Draft)”) approved by the fourth extraordinary general meeting of the company in 2021.
4. The list of incentive objects granted by this incentive plan for the first time meets the qualifications specified in the company law, securities law and other laws, regulations and normative documents as well as the articles of association, meets the conditions of incentive objects specified in the administrative measures, listing rules and other laws, regulations and normative documents, and meets the scope of incentive objects specified in the incentive plan (Draft), The subject qualification as the incentive object of the company’s incentive plan is legal and effective.
In conclusion, the board of supervisors agreed to the list of incentive objects granted for the first time in the incentive plan of the company, and agreed to grant 10.519 million restricted shares to 113 incentive objects with the first grant date of January 7, 2022 and the grant price of 10.97 yuan / share.
It is hereby announced.
Youcare Pharmaceutical Group Co.Ltd(688658) board of supervisors January 7, 2022
